Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Conditions
Interventions
Intervention1: Magnesium sulphate: Patients will be divided in 2 groups. Intervention group will receive magnesium sulphate at infusion rate of 15mg/kg/hr intravenously through CVP intraoperatively an
Sponsors
Hrishikesh Milind Shah
Eligibility
Inclusion criteria
Inclusion criteria: Patients age 40 t0 70 years suffering from diabetes mellitus, ejection faction more than 40 percent
Exclusion criteria
Exclusion criteria: Age less than 40,age more than 70, patients with congestive heart failure, emergency, redo cases, heart rate less than 50 beats per minute, patients with renal and liver impairement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the efficacy of magnesium infusion in reducing blood glucose levelsTimepoint: t0 -baseline, t1-15 minutes after giving medication t2-after giving heparin before grafting t3-reading 30 minutes after giving protamine t4-reading immediately after icu admission t5-reading 6th hour after icu admission t6-reading 12th hour after icu admission t7-reading 24th hour after icu admission. parameters compared are blood sugar levels, magnesium levels, potassium levesl , insulin requirement | — |
Secondary
| Measure | Time frame |
|---|---|
| Requirement of insulin infusion in addition to the safety of the study medication which was assesed by occurence of adverse eventsTimepoint: t0 -baseline, t1-15 minutes after giving medication t2-after giving heparin before grafting t3-reading 30 minutes after giving protamine t4-reading immediately after icu admission t5-reading 6th hour after icu admission t6-reading 12th hour after icu admission t7-reading 24th hour after icu admission. parameters compared are blood sugar levels, magnesium levels, potassium levesl , insulin requirement | — |
Countries
India
Contacts
Public ContactDR Muralidhar Kanchi
Narayana Hrudayalaya Banglore
Outcome results
None listed